Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 23,067 | 14,658 | 9,985 | 33,601 |
| Cost of Goods | N/A | 11,214 | 5,010 | 12,467 | 16,933 |
| Gross Profit | N/A | 11,853 | 9,648 | -2,482 | 16,668 |
| Operating Expenses | 40,962 | 63,732 | 63,607 | 136,758 | 78,701 |
| Operating Income | -40,962 | -51,665 | -53,949 | -138,773 | -61,100 |
| Other Income | -2,102 | -2,024 | -1,944 | -810 | -237 |
| Pre-tax Income | -43,064 | -53,689 | -55,893 | -139,583 | -61,337 |
| Income Tax | N/A | N/A | -23,301 | -19,692 | -2,020 |
| Net Income Continuous | -43,064 | -53,689 | -32,592 | -119,891 | -59,317 |
| Net Income Discontinuous | 2,616 | N/A | 39,565 | 7,476 | N/A |
| Net Income | $-40,448 | $-53,689 | $6,973 | $-112,415 | $-59,317 |
| EPS Basic Total Ops | -442,443.90 | -2.39 | 0.33 | -5.55 | -2.93 |
| EPS Basic Continuous Ops | -471,174.10 | -2.39 | -1.53 | -5.92 | -2.93 |
| EPS Basic Discontinuous Ops | 28,730.13 | N/A | 1.86 | 0.37 | N/A |
| EPS Diluted Total Ops | -442,443.90 | -2.39 | 0.33 | -5.55 | -2.93 |
| EPS Diluted Continuous Ops | -471,174.10 | -2.39 | -1.53 | -5.92 | -2.93 |
| EPS Diluted Discontinuous Ops | 28,730.13 | N/A | 1.86 | 0.37 | N/A |
| EPS Diluted Before Non-Recurring Items | -487,454.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-38,727 | $-49,275 | $-50,822 | $-135,411 | $-58,193 |